Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
Kymera’s pain could be Priovant’s gain
EP Vantage
Tue, 08/30/22 - 11:41 am
Pfizer
hidradenitis suppurativa
Kymera
Priovant
AbbVie
AbbVie fends off patent claim in unusual whistleblower case
Fierce Pharma
Fri, 08/26/22 - 12:18 pm
AbbVie
whistleblower lawsuits
whistleblowers
Allergan
Adamas
Alzheimer's disease
AbbVie, J&J's Imbruvica wins first pediatric nod, this one for chronic graft-versus-host disease
Fierce Pharma
Thu, 08/25/22 - 11:04 am
JNJ
AbbVie
Imbruvica
graft vs host disease
pediatric
FDA
AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program
Endpoints
Tue, 08/16/22 - 11:59 pm
AbbVie
CD47
SEC
clinical trials
I-Mab
Zai Lab
Pursuing AbbVie and J&J, Innovent hits primary endpoint in phase 2 psoriasis trial
Fierce Biotech
Wed, 08/10/22 - 10:49 am
Innovent
AbbVie
JNJ
monoclonal antibodies
psoriasis
clinical trials
'What’s wrong with having lots of patents?' Federal appeals judge sides with AbbVie in Humira case
Endpoints
Tue, 08/2/22 - 11:22 pm
AbbVie
Humira
patents
AbbVie gives Sosei a StaRring role in neurological drug discovery plans, paying $40M and committing $1.2B
Fierce Biotech
Tue, 08/2/22 - 10:48 am
AbbVie
Sosei Heptares
neurological disorders
drug discovery
Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts
Fierce Pharma
Mon, 08/1/22 - 10:53 am
Eli Lilly
AstraZeneca
JNJ
AbbVie
legislation
drug pricing
Medicare
In last Q2 with Humira market lock, AbbVie leans on best-seller to offset Imbruvica losses
Fierce Pharma
Mon, 08/1/22 - 10:35 am
AbbVie
earnings
Humira
FDA reviewing higher dose Hyrimoz biosimilar
Biopharma Reporter
Fri, 07/22/22 - 11:14 am
FDA
Sandoz
biosimilars
Hyrimoz
Humira
AbbVie
AbbVie pens Imbruvica supply pact to support pivotal Oncternal trial
Fierce Biotech
Fri, 07/15/22 - 11:04 am
AbbVie
Oncternal
clinical trials
mantle cell lymphoma
Teva, AbbVie ink $58M opioid settlement to resolve San Francisco claims
Fierce Pharma
Wed, 07/13/22 - 10:39 am
Teva Pharmaceutical
opioids
opioid crisis
San Francisco
legal
AbbVie
Allergan
AbbVie dumps Alector's Alzheimer's immunotherapy after phase 1 review
Fierce Biotech
Fri, 07/8/22 - 10:43 am
Alector
AbbVie
Alzheimer's disease
clinical trials
AL003
AbbVie's Tax Structure in Crosshairs of Senate Finance Committee Report
BioSpace
Thu, 07/7/22 - 06:23 pm
AbbVie
taxes
Senate
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
Motley Fool
Tue, 07/5/22 - 11:05 am
Rinvoq
AbbVie
Europe
ulcerative colitis
Is AbbVie About To Get A New Blockbuster Drug?
Motley Fool
Mon, 06/27/22 - 10:31 am
AbbVie
Parkinson's Disease
ABBV-951
AbbVie Redeems Priority Review Voucher for Rinvoq Approval
BioSpace
Thu, 06/23/22 - 07:53 pm
AbbVie
Rinvoq
priority review
priority review vouchers
ulcerative colitis
AbbVie files Qulipta for chronic migraine prevention
Pharmaforum
Wed, 06/22/22 - 10:21 am
AbbVie
Qulipta
migraines
FDA
More drug, fewer jabs: Novartis' Sandoz eyes EMA nod for high-concentration Humira copy
Fierce Pharma
Mon, 06/20/22 - 10:37 am
Novartis
Sandoz
AbbVie
Humira
Europe
biosimilars
autoimmune disease
EMA
Hyrimoz
Pushing for top spot in Big Pharma, AbbVie lands a key approval for its blockbuster Skyrizi
Endpoints
Mon, 06/20/22 - 10:33 am
AbbVie
Skyrizi
FDA
Crohn’s disease
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »